KMYY(SH:600518) Qi Lu Wan Bao·2025-10-16 01:17Core Viewpoint - The Shanghai Municipal Medical Procurement Management Office announced that certain batches of traditional Chinese medicine (TCM) decoction pieces failed quality inspections, specifically highlighting five batches of He Huan Mi produced by Shanghai De Da Tang Guo Yao Co., Ltd [1][3]. Group 1: Quality Inspection Announcement - The Shanghai Municipal Drug Administration issued a notice regarding the third batch of drug quality inspections for 2025, listing non-compliant TCM decoction pieces [1]. - The announcement advises medical institutions to procure only quality-compliant TCM decoction pieces [1]. Group 2: Company Information - Shanghai De Da Tang Guo Yao Co., Ltd. is located at 2059 Huifeng West Road, Fengxian District, covering an area of 50 acres with a building area of 70,000 square meters, including a workshop area of 43,700 square meters and a warehouse area of over 14,400 square meters [3]. - The company has three independent production lines and a total investment of 300 million yuan [3]. - In 2012, the company was acquired by Kangmei Pharmaceutical Co., Ltd. (stock code 600518), becoming a wholly-owned subsidiary of Guangdong Guangyao Group [3]. Group 3: Legal Issues - Kangmei Pharmaceutical Co., Ltd. and its legal representative, Lai Zhijian, have been restricted from high consumption due to a construction contract dispute [5][7]. - The case is being handled by the Tongliao City Keqi District People's Court, with the execution case number (2025) Nei 0502 Zhi Huan 554 [7].